ANRO
Alto Neuroscience, Inc.
Key Financials
Operating Income
$-66364000
↑ 3.3%
Net Income
$-63238000
↓ 2.9%
Total Liabilities
$33.5M
↑ 28.6%
Total Assets
$184.7M
↑ 4.0%
EPS (Diluted)
$-2.19
↑ 12.4%
Cash & Equivalents
$176.5M
↑ 4.9%
Shareholders' Equity
$151.1M
↓ 0.2%
Operating Cash Flow
$-51769000.00
↓ 9.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ANRO |
| Company Name | Alto Neuroscience, Inc. |
| CIK | 1999480 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 773-255-5012 |